Recent studies demonstrated that NLRP3 inflammasome deficiency reduces cerebral ischemia-reperfusion injury by inhibiting ferroptosis, which may be achieved through the mechanism of the Keap1-Nrf2 pathway (29). The gene discussed is NLRP3; the disease is Cerebral ischemia.